Save Product
Product Details
Background
Recombinant Monoclonal Anti-CD20 Antibody, Mouse (6C8) is a CD20 primary antibody for IHC application. CD20 is expressed on the surface of B cells at all stages of development and differentiation except plasma cells (B cells secreting immunoglobulin). It directly acts on B cells by regulating transmembrane calcium ion flow and plays an important regulatory role in the proliferation and differentiation of B cells.
Product Specifications
Host SpeciesMouseIsotypeMouse IgGClone6C8ApplicationIHC-PDilution Ratio1: 200 - 1: 1000FormLiquidClonalityMonoclonalReactivityHumanSynonymsBp35, Leu-16Concentration0.9~1.1 mg/mlSpecificityReact with CD20 protein on the membrane of target cell/tissuePurification TechProtein APreservationTris buffer, 1% BSAExperiment Protocol
Storage
Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
Avoid freeze / thaw cycle. Upon delivery aliquot. The shelf life is 30 days from the date of opening.ACRO Quality Management System
Customers Also Viewed
Performance Data
Sample Staining Data
Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HGS-S241 at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
Customer Reviews Writing Reviews
Recent Advances
Drug Development Progress- English Name：
B-lymphocyte antigen CD20
- Category：
- Approved Drugs：
35 Details
- Drugs in Clinical Trials：
132 Details
- Highest Development Stage：
Approved
Contact Us
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
Drug Candidate Licensing
